Investors

News Release

<< Back
Codexis to Present at Upcoming Conferences in Brazil and New York

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sep. 13, 2012-- Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced participation at the following upcoming conferences:

World Biofuels Markets Brazil
Date: Tuesday, September 18
Time: 4:20 p.m. BRT
Location: Grand Hyatt Sao Paulo in Sao Paulo, Brazil
Speaker: David Anton, Senior Vice President, Bioindustrials

Credit Suisse 3rd Annual Small & Mid Cap Conference
Date: Thursday, September 20
Time: 8:00 a.m. EDT
Location: New York Palace Hotel in New York, NY
Speaker: John Nicols, President and Chief Executive Officer

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis’ product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.

Source: Codexis, Inc.

Codexis, Inc.
Investors:
Paul Cox, 212-362-1200
ir@codexis.com
Media:
Kelly McAlearney, 415-503-4073
media@codexis.com

Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet
built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue